Form 4: Castle Biosciences Director, Rodney Cotton, Acquires Restricted Stock Units
SEC Form 4 Filing
Director Rodney Cotton acquired 8,673 Restricted Stock Units in Castle Biosciences, vesting in full on May 23, 2025.
Summary
- Rodney Cotton, a director at Castle Biosciences, acquired 8,673 Restricted Stock Units (RSUs) on May 23, 2024.
- Each RSU represents the right to receive one share of Castle Biosciences' Common Stock.
- The RSUs will vest in full on May 23, 2025.
- Following the transaction, Cotton directly owns 8,673 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard insider transaction disclosure. The acquisition of RSUs by a director is generally viewed positively, but it's not a major event.
Positives
- The acquisition of RSUs by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The RSUs vest in full on May 23, 2025, suggesting a one-year horizon for potential stock ownership.
Industry Context
Form 4 filings are routine disclosures of insider transactions, providing transparency to investors about the actions of company insiders.
Stakeholder Impact
- The acquisition of RSUs by a director could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/23/2024 | Date of transaction: Rodney Cotton acquired 8,673 Restricted Stock Units. |
| 05/23/2025 | The RSUs vest in full on the one-year anniversary of the date. |
| 05/28/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.